MPM BioVentures 2018 GP LLC, 10% Owner at Entrada Therapeutics, Inc. (TRDA), sold 89,444 shares at $20.77 ($1.8M) on 2024-12-10, disclosed to the SEC on 2024-12-12.
Open-market sale of $1.8M TRDA by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.77 | 22,935 | $476K | 26.0% |
| 2 | $20.77 | 22,935 | $476K | 26.0% |
| 3 | $20.23 | 21,787 | $441K | 24.0% |
| 4 | $20.23 | 21,787 | $441K | 24.0% |
| Total | $20.51 avg | 89,444 | $1.8M | 100% |
| Filing → |
| ITOS | SELL | 2021-10-18 | $939K | — | Filing → |
| ITOS | SELL | 2021-10-14 | $2.3M | — | Filing → |
| ITOS | SELL | 2021-09-30 | $581K | — | Filing → |